{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:15:41Z","timestamp":1794410141251,"version":"4.9.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":127,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The haemodynamic effects of istaroxime in SCAI stage B cardiogenic shock (CS) due to acute decompensated heart failure (ADHF) have not been evaluated. We assessed the impact of istaroxime on specific invasively-obtained haemodynamic measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In the SEISMiC extension study, 30 patients with ADHF-related SCAI stage B CS were randomized to 60-h intravenous infusion of either placebo (n = 11) or istaroxime at maximum 0.5\u20131.0 \u03bcg\/kg\/min (n = 19). In this post hoc analysis, invasively-obtained haemodynamic measures, simulated group-averaged pressure-volume (PV) loops, and end-systolic elastance (Ees), derived from individual-patient PV relationships, were compared between istaroxime- and placebo-treated patients. Compared with placebo, patients randomized to istaroxime for 48\u201360 h had greater increases in aortic pulsatility index (API) and left ventricular (LV) stroke work index (LVSWI) at 6, 12, 24, and 48 h; and greater increase in pulmonary artery (PA) compliance and reduction in PA elastance at 48 h. At group-averaged PV loop analysis, LV contractility remained stable and right ventricular (RV) contractility tended to deteriorate over time with placebo, whereas LV contractility improved and RV contractility tended to be stabilized with istaroxime. Greater increases in both LV Ees and RV Ees were observed with istaroxime versus placebo from baseline to 48 h.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with ADHF-pre-CS, istaroxime at doses up to 1.0 \u03bcg\/kg\/min for up to 60 h was associated with sustained improvements in measures of LV performance (API and LVSWI), in parallel with increase in PA compliance and reduction in PA elastance at 48 h. As compared with placebo, istaroxime improved LV contractility and preserved RV contractility, which deteriorated on placebo, over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15448","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:03:31Z","timestamp":1760454211000},"page":"3966-3975","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Haemodynamic Effects of Istaroxime in SCAI Stage B HF-Related Cardiogenic Shock: Insights from the SEISMiC Trial"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-7871","authenticated-orcid":false,"given":"Matteo","family":"Pagnesi","sequence":"first","affiliation":[{"name":"Cardiology Unit, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Cotter","sequence":"additional","affiliation":[{"name":"Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]},{"name":"Momentum Research, Inc , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Davison","sequence":"additional","affiliation":[{"name":"Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]},{"name":"Momentum Research, Inc , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mebazaa","sequence":"additional","affiliation":[{"name":"Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]},{"name":"Department of Anesthesiology and Critical Care and Burn Unit, Saint-Louis and Lariboisi\u00e8re Hospitals, FHU PROMICE, DMU Parabol, APHP Nord , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University , Wroc\u0142aw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[{"name":"Emergency Institute for Cardiovascular Diseases \u2018Prof. C.C. Iliescu\u2019 , Bucharest ,","place":["Romania"]},{"name":"University of Medicine Carol Davila , Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Edwards","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takagi","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Tyci\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Intensive Cardiac Care, Medical University of Bia\u0142ystok , Bia\u0142ystok ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Novosadova","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gulati","sequence":"additional","affiliation":[{"name":"CardioVascular Center, Tufts Medical Center , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianela","family":"Barros","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luz","family":"Diaz","sequence":"additional","affiliation":[{"name":"ECLA International , Rosario ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Guardia","sequence":"additional","affiliation":[{"name":"Windtree Therapeutics, Inc , Warrington, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zymli\u0144ski","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University , Wroc\u0142aw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Gajewski","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University , Wroc\u0142aw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University , Wroc\u0142aw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Simmons","sequence":"additional","affiliation":[{"name":"Windtree Therapeutics, Inc , Warrington, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Simonson","sequence":"additional","affiliation":[{"name":"Windtree Therapeutics, Inc , Warrington, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"2026021804154650200_ehf215448-bib-0001","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ejhf.3162","article-title":"Medical therapy of cardiogenic shock: contemporary use of inotropes and vasopressors","volume":"26","author":"Riccardi","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0002","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock \u2013 a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0003","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.jacc.2019.02.051","article-title":"Cardiac calcitropes, myotropes, and mitotropes: JACC review topic of the week","volume":"73","author":"Psotka","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026021804154650200_ehf215448-bib-0004","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1113\/jphysiol.2005.091801","article-title":"Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice","volume":"569","author":"Zhang","year":"2005","journal-title":"J Physiol"},{"key":"2026021804154650200_ehf215448-bib-0005","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/ejhf.2629","article-title":"Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock - a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC)","volume":"24","author":"Metra","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0006","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ehf2.15102","article-title":"Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: design of the SEISMiC trial","volume":"12","author":"Biegus","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0007","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cardfail.2023.03.020","article-title":"Safety and efficacy of istaroxime 1.0 and 1.5 microg\/kg\/min for patients with pre-cardiogenic shock","volume":"29","author":"Metra","year":"2023","journal-title":"J Card Fail"},{"key":"2026021804154650200_ehf215448-bib-0008","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.healun.2025.05.013","article-title":"Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shock","volume":"44","author":"Biegus","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"2026021804154650200_ehf215448-bib-0009","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026021804154650200_ehf215448-bib-0010","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacc.2022.04.049","article-title":"Criteria for defining stages of cardiogenic shock severity","volume":"80","author":"Kapur","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026021804154650200_ehf215448-bib-0011","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cardfail.2015.12.012","article-title":"Cardiovascular simulation of heart failure pathophysiology and therapeutics","volume":"22","author":"Doshi","year":"2016","journal-title":"J Card Fail"},{"key":"2026021804154650200_ehf215448-bib-0012","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021584","article-title":"Comprehensive physiological modeling provides novel insights into heart failure with preserved ejection fraction physiology","volume":"10","author":"Kaye","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026021804154650200_ehf215448-bib-0013","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.jacc.2022.02.050","article-title":"Venous tone and stressed blood volume in heart failure: JACC review topic of the week","volume":"79","author":"Fudim","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026021804154650200_ehf215448-bib-0014","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026021804154650200_ehf215448-bib-0015","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1002\/ehf2.14510","article-title":"Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction","volume":"10","author":"Bertaina","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0016","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cardfail.2021.08.014","article-title":"De novo vs acute-on-chronic presentations of heart failure-related cardiogenic shock: insights from the critical care cardiology trials network registry","volume":"27","author":"Bhatt","year":"2021","journal-title":"J Card Fail"},{"key":"2026021804154650200_ehf215448-bib-0017","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/ejhf.3082","article-title":"Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock","volume":"26","author":"Sundermeyer","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0018","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/ejhf.1743","article-title":"Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial","volume":"22","author":"Carubelli","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0019","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24277","article-title":"PREDICT HF: risk stratification in advanced heart failure using novel hemodynamic parameters","volume":"47","author":"Cyrille-Superville","year":"2024","journal-title":"Clin Cardiol"},{"key":"2026021804154650200_ehf215448-bib-0020","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/ehf2.13246","article-title":"Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial","volume":"8","author":"Belkin","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0021","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.120.012002","article-title":"Is left ventricular stroke work index useful in the cardiac intensive care unit?","volume":"13","author":"Clark","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026021804154650200_ehf215448-bib-0022","doi-asserted-by":"publisher","first-page":"H501","DOI":"10.1152\/ajpheart.00138.2005","article-title":"Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers","volume":"289","author":"Burkhoff","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026021804154650200_ehf215448-bib-0023","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/0002-9149(77)90192-8","article-title":"End-systolic pressure\/volume ratio: a new index of ventricular contractility","volume":"40","author":"Sagawa","year":"1977","journal-title":"Am J Cardiol"},{"key":"2026021804154650200_ehf215448-bib-0024","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1086\/676020","article-title":"Determinants of right ventricular afterload (2013 Grover conference series)","volume":"4","author":"Tedford","year":"2014","journal-title":"Pulm Circ"},{"key":"2026021804154650200_ehf215448-bib-0025","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/01.cir.86.2.513","article-title":"Effective arterial elastance as index of arterial vascular load in humans","volume":"86","author":"Kelly","year":"1992","journal-title":"Circulation"},{"key":"2026021804154650200_ehf215448-bib-0026","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cardfail.2021.07.013","article-title":"Right ventricular dysfunction is common and identifies patients at risk of dying in cardiogenic shock","volume":"27","author":"Jain","year":"2021","journal-title":"J Card Fail"},{"key":"2026021804154650200_ehf215448-bib-0027","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/ehjacc\/zuad095","article-title":"Prognostic significance of haemodynamic parameters in patients with cardiogenic shock","volume":"12","author":"Berg","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026021804154650200_ehf215448-bib-0028","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099","article-title":"Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock","volume":"13","author":"Thayer","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0029","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ejhf.504","article-title":"Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure","volume":"18","author":"Frea","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0030","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ejhf.533","article-title":"Advanced heart failure: look right to prognosticate right!","volume":"18","author":"Van Aelst","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026021804154650200_ehf215448-bib-0031","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jchf.2023.05.007","article-title":"Clinical course of patients in cardiogenic shock stratified by phenotype","volume":"11","author":"Zweck","year":"2023","journal-title":"JACC Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/6\/3966\/66968084\/eschf_12_6_3966.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/6\/3966\/66968084\/eschf_12_6_3966.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:15:53Z","timestamp":1771406153000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/6\/3966\/8488163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,10,14]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15448","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"2025-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}